SCHEMBL4099237

SCHEMBL4099237

CCO[Si](OCC)(OCC)c1c2ccccc2cc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
HTR2A P28223 1/20 0.39
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 3/20 0.35
HIF1A Q16665 1/20 0.35
CYP1B1 Q16678 1/20 0.35
BTK Q06187 1/20 0.35
CYP1A2 P05177 4/20 0.35
CYP2A6 P11509 1/20 0.35
KDM4E B2RXH2 5/20 0.35
HPGD P15428 3/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6748665 0.93 NR1I2 (0.36) NR1I2L3MBTL1HTR2AALDH1A1HSD17B10
SCHEMBL1639907 0.86 NR1I2 (0.33) NR1I2L3MBTL1HTR2AALDH1A1HSD17B10
SCHEMBL3350607 0.86 GABRP (0.36) L3MBTL1ALDH1A1CYP1A2KDM4EHPGD
SCHEMBL16709834 0.82 NR1I2 (0.30) NR1I2
SCHEMBL27773337 0.81 NR1I2 (0.38) NR1I2L3MBTL1HTR2AALDH1A1HSD17B10
SCHEMBL1639321 0.80 ALDH1A1 (0.37) L3MBTL1ALDH1A1HSD17B10CYP1A2CYP2A6
SCHEMBL28262655 0.80 CYP1A2 (0.33) NR1I2L3MBTL1HTR2AALDH1A1HSD17B10
SCHEMBL6697302 0.79 ALDH1A1 (0.38) L3MBTL1ALDH1A1HSD17B10CYP2A6KDM4E
SCHEMBL2352239 0.79 CYP2A6 (0.35) NR1I2L3MBTL1ALDH1A1HSD17B10HIF1A
SCHEMBL1929080 0.78 TRPM4 (0.38) NR1I2L3MBTL1HTR2AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090246716-A1 HIGH REFRACTIVE INDEX SOL-GEL COMPOSITION AND METHOD OF MAKING PHOTO-PATTERNED STRUCTURES ON A SUBSTRATE NITTO DENKO CORPORATION (JP) 2009-10-01 US disclosed
US-20090246716-A1 HIGH REFRACTIVE INDEX SOL-GEL COMPOSITION AND METHOD OF MAKING PHOTO-PATTERNED STRUCTURES ON A SUBSTRATE NITTO DENKO CORPORATION (JP) 2009-10-01 US disclosed
WO-2009120410-A2 HIGH REFRACTIVE INDEX SOL-GEL COMPOSITION AND METHOD OF MAKING PHOTO-PATTERNED STRUCTURES ON A SUBSTRATE NITTO DENKO CORPORATION (JP) 2009-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090246716-A1 HIGH REFRACTIVE INDEX SOL-GEL COMPOSITION AND METHOD OF MAKING PHOTO-PATTERNED STRUCTURES ON A SUBSTRATE SOS1, SOS2, MMS19 NR1I2 592/4885L3MBTL1 2555/4885HTR2A 4419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.